Activation of neuronal TRPV1 is sufficient to cause the equivalent of psoriasis July 26, 2019 No Comments
Arcutis reports promising topline phase IIb data on ARQ-151 for plaque psoriasis July 23, 2019 No Comments
Affibody completes 12-week interim analysis of phase II psoriasis study of ABY-035 July 17, 2019 No Comments
Pfizer initiates phase II study of PF-06826647 for the treatment of plaque psoriasis July 12, 2019 No Comments
First patient dosed in phase II study of KD-025 in cutaneous systemic sclerosis July 11, 2019 No Comments
Cara initiates phase II trial of oral difelikefalin to treat pruritus in atopic dermatitis July 10, 2019 No Comments
Zhengzhou University describes Helicobacter pylori-neutrophil activating proteins July 9, 2019 No Comments
Promising topline results presented from phase III program of Epsolay in papulopustular rosacea July 9, 2019 No Comments
RSS